Fatal anaphylaxis with neuromuscular blocking agents: a risk factor and management analysis-Reference-Cited by-同舟云学术

Fatal anaphylaxis with neuromuscular blocking agents: a risk factor and management analysis

Author:

Reitter M.¹,Petitpain N.²,Latarche C.³,Cottin J.⁴,Massy N.⁵,Demoly P.⁶,Gillet P.⁷,Mertes P. M.⁸,

Affiliation:

1. Department of Anesthesia; University Hospital of Nancy; Nancy France

2. Regional Pharmacovigilance Centre of Nancy; University Hospital of Nancy; Nancy France

3. Department of Epidemiology; University Hospital of Nancy; Vandoeuvre lès Nancy France

4. Regional Pharmacovigilance Centre of Lyon; University Hospital of Lyon; Lyon France

5. Regional Pharmacovigilance Centre of Rouen; University Hospital of Rouen; Rouen France

6. Department of Allergology; University Hospital of Montpellier; Montpellier France

7. Department of Clinical Pharmacology; University Hospital of Nancy; Nancy France

8. Department of Anesthesia; CHRU of Strasbourg; Nouvel Hôpital Civil; Strasbourg France

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference27 articles.

5. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice;Mertes;J Investig Allergol Clin Immunol,2011

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献